© Drug Hunter Inc. 2018-2023
Home > S64315
potent and selective Mcl-1 PPI inhibitor
completed Ph. I in AML/MDS (IV weekly)
from NMR fragment screening and SBDD
J. Med. Chem., Nov. 4, 2020
Servier, HU + FR / Vernalis, UK
Servier selective clinical Mcl-1 protein-protein interaction (PPI) inhibitor
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
Molecules of the Month
Molecule of the Year